Increased GST and/or GT tumor expression, generally considered as a bad prognosis marker (associated with drug resistance and disease progression), and could potentially be used as a predictive marker, allowing doctors, after biopsy, to identify which patients will respond best to GST or GT-activated prodrugs
The present study demonstrated that CP treatment develops HC with associated histopathological changes, CNP upregulation, increased hepatic pro-inflammatory cytokines and oxidative stress, and Augmented protein levels of NF-B, and MAPKs
Evaluation of the clinical efficacy of benazepril in the treatment of chronic renal insufficiency in cats
Those treated with semaglutide experienced an average weight loss of 12.4% from their initial body weight compared to the placebo group
The low and slow SmartDose dosing protocol acknowledges individual variability and prioritizes patient comfort, preventing unnecessary dropout while using the minimal effective medication dose